Symbols

NUWE

Nuwellis·NASDAQ

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 2

Significant Inflow of Main Funds

Ample Liquidity

High Gross Profit Margin

EPS Below Expectations

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NUWE

Nuwellis, Inc.

A medical technology company that manufactures Aquadex SmartFlow system for ultrafiltration therapy to treat Hypervolemia

Industry

Healthcare Equipment and Supplies

Established Date

08/22/2002

Listing Date

02/16/2012

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.nuwellis.com

Security Type

Common stock

Office address

12988 Valley View Road, Eden Prairie, Minnesota 55344

Business

Introduction

Nuwellis, Inc., was incorporated in Delaware on August 22, 2002. The Company commenced operations in November 1999 through Sunshine Heart, Inc. Pte Ltd., and is currently a wholly-owned subsidiary of Sunshine Heart, Inc. Pte Ltd., in Australia. Nuwellis a medical technology company dedicated to improving the lives of patients with fluid overload through science, collaboration and innovative technologies. Nuwellis is committed to advancing the development of heart and kidney care by providing patients with earlier, safer and more controllable fluid management. The Company focuses on the development, production and sale of medical devices for ultrafiltration therapy, including the Aquadex FlexFlow and Aquadex SmartFlow systems (collectively, the "Aquadex Systems ").

Company Financials

EPS

NUWE has released its 2025 Q4 earnings. EPS was reported at -1.5, versus the expected -0.21, missing expectations. The chart below visualizes how NUWE has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

NUWE has released its 2025 Q4 earnings report, with revenue of 2.42M, reflecting a YoY change of 4.39%, and net profit of -2.42M, showing a YoY change of -64.99%. The Sankey diagram below clearly presents NUWE's revenue sources and cost distribution.